Phase
Condition
Gall Bladder Disorders
Liver Disorders
Treatment
Functional fatty acids
Placebo
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm
Exclusion
Exclusion Criteria:
History of ERCP (Endoscopic Retrograde Cholangiopancreatography)
Previous gallstone removal surgery with gallbladder preservation
History of acute or chronic pancreatitis, cholangitis
Mirizzi Syndrome
History of gastrointestinal surgery
Gastrointestinal obstruction
Dysfunction of the sphincter of Oddi
Gallbladder neck polyps
Abnormal gallbladder structure
Gallbladder mass
Biliary infection or stones
Congenital biliary abnormalities
Biliary injury or surgery
Biliary tumors
Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
Significant arrhythmia, bradycardia, or atrioventricular block
Severe hypertension, liver or kidney insufficiency
Immune, endocrine, hematological, or mental disorders
Severe cerebrovascular disease
Allergy to relevant foods
Pregnant or breastfeeding women
Unwillingness or inability to consent to participation
Study Design
Study Description
Connect with a study center
Long Deng
Lanzhou, Gansu 730000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.